Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Sep 16, 2017; 9(9): 480-485
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.480
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.480
Table 1 Characteristics of the entire cohort and the subset evaluated for efficacy n (%)
Patients analyzed for efficacy n = 33 | Entire cohort n = 45 | |
Age, mean ± SD, yr | 66 ± 8.7 (range 47-80) | 66 ± 8.7 (range 47-87) |
Age > 65 yr | 17 (52) | 22 (49) |
Male gender | 21 (64) | 32 (71) |
Barrett’s length, mean ± SD, in cm | 3.3 ± 2.1 (range 0.8-7) | 3.4 ± 2.2 (range 0.8-8) |
Short segment (≤ 3 cm) | 58% | 56% |
Long segment (4-10 cm) | 42% | 44% |
History of ablative therapy | 6 (18) | 12 (27) |
IM at baseline | 5 (15) | 7 (16) |
LGD at baseline | 5 (15) | 7 (16) |
HGD at baseline | 15 (45) | 19 (42) |
IMC at baseline | 8 (24) | 12 (27) |
Years observed, mean ± SD, yr | 2.3 ± 1.1 yr (range 1-4) | Entire study duration (4 yr) |
Table 2 Treatment response
Pathology after cryotherapy treatments | ||||||
Baseline Pathology | Complete regression | IM | LGD | HGD | IMC | Total |
IM | 4 | 1 | 0 | 0 | 0 | 5 |
LGD | 3 | 2 | 0 | 0 | 0 | 5 |
HGD | 5 | 8 | 1 | 1 | 0 | 15 |
IMC | 4 | 2 | 0 | 0 | 2 | 8 |
- Citation: Suchniak-Mussari K, Dye CE, Moyer MT, Mathew A, McGarrity TJ, Gagliardi EM, Maranki JL, Levenick JM. Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett’s esophagus. World J Gastrointest Endosc 2017; 9(9): 480-485
- URL: https://www.wjgnet.com/1948-5190/full/v9/i9/480.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i9.480